Tenaya Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-124.08	-123.67	-72.72	-38.4	-26.23
Depreciation & Amortization	11.82	8.71	4.03	2.48	1.99
Share-Based Compensation	15.31	11.47	2.95	0.74	0.41
Other Operating Activities	-5.12	-0.94	4.93	-0.28	-0.27
Operating Cash Flow	-102.07	-104.42	-60.81	-35.45	-24.1
Capital Expenditures	-1.24	-20.63	-25.12	-9.76	-2.93
Change in Investments	49.98	104.27	-213.44	2.75	-2.66
Other Investing Activities	-0.03	0.01	-	-	-
Investing Cash Flow	48.72	83.65	-238.56	-7.01	-5.58
Share Issuance / Repurchase	4.55	77.77	188.9	0.03	0.07
Other Financing Activities	-0.5	-	20.07	147.24	30.45
Financing Cash Flow	4.05	77.77	208.97	147.27	30.51
Net Cash Flow	-49.31	57	-90.41	104.81	0.83
Free Cash Flow	-103.31	-125.05	-85.93	-45.21	-27.02
Free Cash Flow Per Share	-1.40	-2.79	-4.85	-46.51	-5.96

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).